We interview extraordinary medtech leaders to learn about who they are as people. What is their background? How did they get to where they are, and where do they plan to go from here? Most importantly, what attracted them to the medtech industry specifically? We love hearing a wide variety of stories, conventional and unconventional, from an assortment of diverse perspectives. These people are making a profound difference, and we’re excited to share why and how. You’ll hear from CEOs, engineers, scientists, researchers, and more. If you ever wanted to get to know some of your favorite medtech leaders on a more personal level, now’s your chance. Discover what makes The Leading Difference.
All content for The Leading Difference is the property of Velentium and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
We interview extraordinary medtech leaders to learn about who they are as people. What is their background? How did they get to where they are, and where do they plan to go from here? Most importantly, what attracted them to the medtech industry specifically? We love hearing a wide variety of stories, conventional and unconventional, from an assortment of diverse perspectives. These people are making a profound difference, and we’re excited to share why and how. You’ll hear from CEOs, engineers, scientists, researchers, and more. If you ever wanted to get to know some of your favorite medtech leaders on a more personal level, now’s your chance. Discover what makes The Leading Difference.
Sara Aswegan | Strategic Advisor | Rare Disease Advocacy, Patient-Centric Solutions, & Global Collaboration
The Leading Difference
30 minutes
1 month ago
Sara Aswegan | Strategic Advisor | Rare Disease Advocacy, Patient-Centric Solutions, & Global Collaboration
Sarah Aswegan, a seasoned biopharma leader and strategic advisor for global rare disease solutions, shares her journey from sales in pharma to her consulting work today. She discusses her experience in transitioning biopharma companies from clinical to commercial success, the evolution of medtech in diagnosing and managing rare diseases, and the collaborative efforts required to bring innovative treatments to market. She also shares insights on current trends in gene therapy, the dynamics of funding, and the importance of data in advancing care for rare disease patients.
The Leading Difference
We interview extraordinary medtech leaders to learn about who they are as people. What is their background? How did they get to where they are, and where do they plan to go from here? Most importantly, what attracted them to the medtech industry specifically? We love hearing a wide variety of stories, conventional and unconventional, from an assortment of diverse perspectives. These people are making a profound difference, and we’re excited to share why and how. You’ll hear from CEOs, engineers, scientists, researchers, and more. If you ever wanted to get to know some of your favorite medtech leaders on a more personal level, now’s your chance. Discover what makes The Leading Difference.
